Marya D. Zilberberg, MD, MPH, FCCP

Marya D. Zilberberg founded EviMed Research Group, LLC, in 2007, and currently serves as its President and CEO. EviMed, which came out of Zilberberg’s two decades of work in evidence-based medicine (EBM) and outcomes research, is a research and scientific communication consultancy specializing in epidemiology, evidence-based medicine, health services and outcomes research. Our area of focus is prevention and management of healthcare-associated complications and promotion of efficient and high quality healthcare delivery with the emphasis on hospital and ICU settings. For the last decade we have been intimately involved in developing evidence for the value proposition of multiple biopharmaceutical and device technologies, as well as methods for conducting comparative effectiveness research.

In addition to serving as EviMed’s President, Zilberberg is an Adjunct Associate Professor at the School of Public Health and Health Sciences at the University of Massachusetts, Amherst, and a Senior Fellow at the Jefferson School of Population Health, Thomas Jefferson University, Philadelphia, PA. She has authored or co-authored over 150 peer-reviewed articles, scientific presentations and book chapters, including systematic reviews, meta-analyses and cost-effectiveness models. She serves on the editorial boards for Critical Care Medicine and Comparative Effectiveness Research, and peer reviews for multiple other journals. In addition to being an active member of several professional societies, she is a member of the leadership of the American College of Chest Physicians. She is a frequent invited speaker on evidence-based healthcare, research methods, as well as healthcare-associated complications, and has delivered dozens of Grand Rounds and other keynote presentations.

You can follow Dr. Zilberberg on Twitter and read her personal blog Healthcare, etc. Her LinkedIn profile can be found here, and you can “Like” Healthcare, etc. Facebook page




Comments are closed.